Status:
RECRUITING
Comparative Study of Blood Loss in Total Laparoscopic Hysterectomy by Ligation the Uterine Arteries in Different Techniques.
Lead Sponsor:
Mostafa Bahaa
Conditions:
Gynecologic Disease
Eligibility:
FEMALE
35-60 years
Phase:
NA
Brief Summary
Following Caesarean section, hysterectomy is the second most common major gynecological surgery, with approximately 600,000 procedures performed annually in the USA. Since Reich et al. first reported ...
Eligibility Criteria
Inclusion
- Patients aged between 35-60 years Patients presented with menometrorrhagia unresponsive to medical treatment, and uterine pathology such as adenomyosis or multiple fibroids.
Exclusion
- Patients were excluded if they had: medical conditions preventing pneumo-peritoneum
- Patients with medical conditions hindering proper ventilation during general anesthesia.
- Patients diagnosed with endometrial carcinoma and patients with uterine size larger than 24 weeks were excluded.
- Patients with excessive adhesions precluding access to the uterine arteries were not enrolled in the study.
Key Trial Info
Start Date :
March 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06875518
Start Date
March 12 2025
End Date
December 20 2025
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mostafa Bahaa
Damietta, New Damietta, Egypt, 34518